Page 1

Danaher Corporation Investors DANAHER REPORTS SECOND QUARTER 2021 RESULTS WASHINGTON , July 22 , 2021 / PRNewswire / -- Danaher Corporation ( NYSE : DHR ) ( the " Company " ) today announced results for the second quarter 2021 . All results in this release reflect only continuing operations unless otherwise noted . For the quarter ended July 2 , 2021 , net earnings were $ 1.7 billion , or $ 2.28 per diluted common share which represents an 84.0 % year - over - year increase from the comparable 2020 period . Non - GAAP adjusted diluted net earnings per common share were $ 2.46 which represents a 71.0 % increase over the comparable 2020 period . Revenues increased 36.5 % year - over - year to $ 7.2 billion , with 31.5 % non - GAAP core revenue growth . Operating cash flow for the second quarter was $ 2.1 billion , representing a 46.5 % increase year - over - year , and non - GAAP free cash flow was $ 1.8 billion , representing a 41.0 % increase year - over - year . For the third quarter 2021 , the Company anticipates that non - GAAP core revenue growth will be in the mid- to high - teens percent range . For the full year 2021 , the Company now anticipates that the non - GAAP core revenue growth rate including Cytiva will be approximately 20 % . Rainer M. Blair , President and Chief Executive Officer , stated , " Broad - based strength across the portfolio helped us deliver over 30 % core revenue growth and outstanding earnings per share growth and cash flow generation . We continued to make significant growth investments during the quarter , strengthening our organic growth trajectory and enhancing our portfolio with the announcement of our pending acquisition of Aldevron . " Blair continued , " We believe the combination of our leading portfolio and DBS - driven execution differentiates Danaher today and provides a strong foundation for sustainable , long - term outperformance . " Danaher will discuss its results during its quarterly investor conference call today starting at 8:00 a.m. ET . The call and an accompanying slide presentation will be webcast on the " Investors " section of Danaher's website , www.danaher.com , under the subheading " Events & Presentations . " A replay of the webcast will be available in the same section of Danaher's website shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call . The conference call can be accessed by dialing 866-503-8675 within the U.S. or by dialing + 1-786-815-8792 outside the U.S. a few minutes before the 8:00 a.m. ET start and telling the operator that you are dialing in for Danaher's earnings conference call ( access code 5932469 ) . A replay of the conference call will be available shortly after the conclusion of the call and until August 5 , 2021. You can access the replay dial - in information on the " Investors " section of Danaher's website under the subheading " Events & Presentations . " In addition , presentation materials relating to Danaher's results have been posted to the " Investors " section of Danaher's website under the subheading " Quarterly Earnings . " ABOUT DANAHER Danaher is a global science and technology innovator committed to helping its customers solve complex challenges and improving quality of life around the world . Its family of world class brands has leadership positions in the demanding and attractive health care , environmental and applied end - markets . With more than 20 operating companies , Danaher's globally diverse team of approximately 69,000 associates is united by a common culture and operating system , the Danaher Business System , and its Shared Purpose , Helping Realize Life's Potential . For more information , please visit www.danaher.com . NON - GAAP MEASURES In addition to the financial measures prepared in accordance with generally accepted accounting principles ( GAAP ) , this earnings release also contains non - GAAP financial measures . Calculations of these measures , the reasons why we believe these measures provide useful information to investors , a reconciliation of these measures to the most directly comparable GAAP measures , as applicable , and other information relating to these non - GAAP measures are included in the supplemental reconciliation schedule attached . FORWARD - LOOKING STATEMENTS Statements in this release that are not strictly historical , including the statements regarding the Company's expected financial performance for the third quarter and full year 2021 , the Company's anticipated acquisition of Aldevron , L.L.C. , Danaher's positioning for sustainable , long - term performance and any other statements regarding events or developments that we believe or anticipate will or may occur in the future are " forward - looking " statements within the meaning of the federal securities laws . There are a number of important factors that could cause actual results , developments and business decisions to differ materially from those suggested or indicated by such forward - looking statements and you should not place undue reliance on any such forward - looking statements . These factors include , among other things , the uncertainty of regulatory approvals for our acquisition of Aldevron and the timing or conditionality thereof , the ability of Danaher and Aldevron to satisfy the acquisition agreement conditions and consummate the transaction , the highly uncertain and unpredictable severity , magnitude and duration of the COVID - 19 pandemic ( and the related governmental , business and community responses thereto ) on our business , results of operations and financial condition , the impact of our debt obligations ( including the debt incurred to finance the acquisition of Cytiva and any debt we may incur to finance the acquisition of Aldevron ) on our operations and liquidity , deterioration of or instability in the economy , the markets we or Aldevron serve and the financial markets ( including as a result of the COVID - 19 pandemic ) , uncertainties relating to U.S. laws or policies , including potential changes in U.S. trade policies and tariffs and the reaction of other countries thereto , contractions or growth rates and